Analytical validation of a new point-of-care assay for serum amyloid A in horses

D. Schwartz, Nicola Pusterla, S. Jacobsen, Mary M Christopher

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Serum amyloid A (SAA) is a major acute phase protein in horses. A new point-of-care (POC) test for SAA (Stablelab) is available, but studies evaluating its analytical accuracy are lacking. Objectives: To evaluate the analytical performance of the SAA POC test by 1) determining linearity and precision, 2) comparing results in whole blood with those in serum or plasma, and 3) comparing POC results with those obtained using a previously validated turbidimetric immunoassay (TIA). Study design: Assay validation. Methods: Analytical validation of the POC test was done in accordance with American Society of Veterinary Clinical Pathology guidelines using residual equine serum/plasma and whole blood samples from the Clinical Pathology Laboratory at the University of California-Davis. A TIA was used as the reference method. We also evaluated the effect of haematocrit (HCT). Results: The POC test was linear for SAA concentrations of up to at least 1000 μg/mL (r = 0.991). Intra-assay CVs were 13, 18 and 15% at high (782 μg/mL), intermediate (116 μg/mL) and low (64 μg/mL) concentrations. Inter-assay (inter-batch) CVs were 45, 14 and 15% at high (1372 μg/mL), intermediate (140 μg/mL) and low (56 μg/mL) concentrations. SAA results in whole blood were significantly lower than those in serum/plasma (P = 0.0002), but were positively correlated (r = 0.908) and not affected by HCT (P = 0.261); proportional negative bias was observed in samples with SAA>500 μg/mL. The difference between methods exceeded the 95% confidence interval of the combined imprecision of both methods (15%). Main limitations: Analytical validation could not be performed in whole blood, the sample most likely to be used stall side. Conclusion: The POC test has acceptable accuracy and precision in equine serum/plasma with SAA concentrations of up to at least 1000 μg/mL. Low inter-batch precision at high concentrations may affect serial measurements, and the use of the same test batch and sample type (serum/plasma or whole blood) is recommended. Comparison of results between the POC test and the TIA is not recommended.

Original languageEnglish (US)
Pages (from-to)678-683
Number of pages6
JournalEquine Veterinary Journal
Volume50
Issue number5
DOIs
StatePublished - Sep 1 2018

Fingerprint

Point-of-Care Systems
Serum Amyloid A Protein
amyloid
blood serum
Horses
horses
assays
Immunoassay
Serum
Clinical Pathology
Hematocrit
immunoassays
blood
testing
Veterinary Pathology
Acute-Phase Proteins
hematocrit
sampling
acute phase proteins
Guidelines

Keywords

  • acute phase protein
  • analytical accuracy
  • horse
  • point-of-care systems
  • serum amyloid A

ASJC Scopus subject areas

  • Equine

Cite this

Analytical validation of a new point-of-care assay for serum amyloid A in horses. / Schwartz, D.; Pusterla, Nicola; Jacobsen, S.; Christopher, Mary M.

In: Equine Veterinary Journal, Vol. 50, No. 5, 01.09.2018, p. 678-683.

Research output: Contribution to journalArticle

@article{1c7985ff81a4455a99621c6ce24a532b,
title = "Analytical validation of a new point-of-care assay for serum amyloid A in horses",
abstract = "Background: Serum amyloid A (SAA) is a major acute phase protein in horses. A new point-of-care (POC) test for SAA (Stablelab) is available, but studies evaluating its analytical accuracy are lacking. Objectives: To evaluate the analytical performance of the SAA POC test by 1) determining linearity and precision, 2) comparing results in whole blood with those in serum or plasma, and 3) comparing POC results with those obtained using a previously validated turbidimetric immunoassay (TIA). Study design: Assay validation. Methods: Analytical validation of the POC test was done in accordance with American Society of Veterinary Clinical Pathology guidelines using residual equine serum/plasma and whole blood samples from the Clinical Pathology Laboratory at the University of California-Davis. A TIA was used as the reference method. We also evaluated the effect of haematocrit (HCT). Results: The POC test was linear for SAA concentrations of up to at least 1000 μg/mL (r = 0.991). Intra-assay CVs were 13, 18 and 15{\%} at high (782 μg/mL), intermediate (116 μg/mL) and low (64 μg/mL) concentrations. Inter-assay (inter-batch) CVs were 45, 14 and 15{\%} at high (1372 μg/mL), intermediate (140 μg/mL) and low (56 μg/mL) concentrations. SAA results in whole blood were significantly lower than those in serum/plasma (P = 0.0002), but were positively correlated (r = 0.908) and not affected by HCT (P = 0.261); proportional negative bias was observed in samples with SAA>500 μg/mL. The difference between methods exceeded the 95{\%} confidence interval of the combined imprecision of both methods (15{\%}). Main limitations: Analytical validation could not be performed in whole blood, the sample most likely to be used stall side. Conclusion: The POC test has acceptable accuracy and precision in equine serum/plasma with SAA concentrations of up to at least 1000 μg/mL. Low inter-batch precision at high concentrations may affect serial measurements, and the use of the same test batch and sample type (serum/plasma or whole blood) is recommended. Comparison of results between the POC test and the TIA is not recommended.",
keywords = "acute phase protein, analytical accuracy, horse, point-of-care systems, serum amyloid A",
author = "D. Schwartz and Nicola Pusterla and S. Jacobsen and Christopher, {Mary M}",
year = "2018",
month = "9",
day = "1",
doi = "10.1111/evj.12807",
language = "English (US)",
volume = "50",
pages = "678--683",
journal = "Equine veterinary journal. Supplement",
issn = "2042-3306",
publisher = "British Equine Veterinary Association",
number = "5",

}

TY - JOUR

T1 - Analytical validation of a new point-of-care assay for serum amyloid A in horses

AU - Schwartz, D.

AU - Pusterla, Nicola

AU - Jacobsen, S.

AU - Christopher, Mary M

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Background: Serum amyloid A (SAA) is a major acute phase protein in horses. A new point-of-care (POC) test for SAA (Stablelab) is available, but studies evaluating its analytical accuracy are lacking. Objectives: To evaluate the analytical performance of the SAA POC test by 1) determining linearity and precision, 2) comparing results in whole blood with those in serum or plasma, and 3) comparing POC results with those obtained using a previously validated turbidimetric immunoassay (TIA). Study design: Assay validation. Methods: Analytical validation of the POC test was done in accordance with American Society of Veterinary Clinical Pathology guidelines using residual equine serum/plasma and whole blood samples from the Clinical Pathology Laboratory at the University of California-Davis. A TIA was used as the reference method. We also evaluated the effect of haematocrit (HCT). Results: The POC test was linear for SAA concentrations of up to at least 1000 μg/mL (r = 0.991). Intra-assay CVs were 13, 18 and 15% at high (782 μg/mL), intermediate (116 μg/mL) and low (64 μg/mL) concentrations. Inter-assay (inter-batch) CVs were 45, 14 and 15% at high (1372 μg/mL), intermediate (140 μg/mL) and low (56 μg/mL) concentrations. SAA results in whole blood were significantly lower than those in serum/plasma (P = 0.0002), but were positively correlated (r = 0.908) and not affected by HCT (P = 0.261); proportional negative bias was observed in samples with SAA>500 μg/mL. The difference between methods exceeded the 95% confidence interval of the combined imprecision of both methods (15%). Main limitations: Analytical validation could not be performed in whole blood, the sample most likely to be used stall side. Conclusion: The POC test has acceptable accuracy and precision in equine serum/plasma with SAA concentrations of up to at least 1000 μg/mL. Low inter-batch precision at high concentrations may affect serial measurements, and the use of the same test batch and sample type (serum/plasma or whole blood) is recommended. Comparison of results between the POC test and the TIA is not recommended.

AB - Background: Serum amyloid A (SAA) is a major acute phase protein in horses. A new point-of-care (POC) test for SAA (Stablelab) is available, but studies evaluating its analytical accuracy are lacking. Objectives: To evaluate the analytical performance of the SAA POC test by 1) determining linearity and precision, 2) comparing results in whole blood with those in serum or plasma, and 3) comparing POC results with those obtained using a previously validated turbidimetric immunoassay (TIA). Study design: Assay validation. Methods: Analytical validation of the POC test was done in accordance with American Society of Veterinary Clinical Pathology guidelines using residual equine serum/plasma and whole blood samples from the Clinical Pathology Laboratory at the University of California-Davis. A TIA was used as the reference method. We also evaluated the effect of haematocrit (HCT). Results: The POC test was linear for SAA concentrations of up to at least 1000 μg/mL (r = 0.991). Intra-assay CVs were 13, 18 and 15% at high (782 μg/mL), intermediate (116 μg/mL) and low (64 μg/mL) concentrations. Inter-assay (inter-batch) CVs were 45, 14 and 15% at high (1372 μg/mL), intermediate (140 μg/mL) and low (56 μg/mL) concentrations. SAA results in whole blood were significantly lower than those in serum/plasma (P = 0.0002), but were positively correlated (r = 0.908) and not affected by HCT (P = 0.261); proportional negative bias was observed in samples with SAA>500 μg/mL. The difference between methods exceeded the 95% confidence interval of the combined imprecision of both methods (15%). Main limitations: Analytical validation could not be performed in whole blood, the sample most likely to be used stall side. Conclusion: The POC test has acceptable accuracy and precision in equine serum/plasma with SAA concentrations of up to at least 1000 μg/mL. Low inter-batch precision at high concentrations may affect serial measurements, and the use of the same test batch and sample type (serum/plasma or whole blood) is recommended. Comparison of results between the POC test and the TIA is not recommended.

KW - acute phase protein

KW - analytical accuracy

KW - horse

KW - point-of-care systems

KW - serum amyloid A

UR - http://www.scopus.com/inward/record.url?scp=85051223237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051223237&partnerID=8YFLogxK

U2 - 10.1111/evj.12807

DO - 10.1111/evj.12807

M3 - Article

C2 - 29344980

AN - SCOPUS:85051223237

VL - 50

SP - 678

EP - 683

JO - Equine veterinary journal. Supplement

JF - Equine veterinary journal. Supplement

SN - 2042-3306

IS - 5

ER -